213 related articles for article (PubMed ID: 2644820)
1. The usefulness of branched chain amino acids in patients with acute or chronic hepatic encephalopathy.
Alexander WF; Spindel E; Harty RF; Cerda JJ
Am J Gastroenterol; 1989 Feb; 84(2):91-6. PubMed ID: 2644820
[TBL] [Abstract][Full Text] [Related]
2. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
Holecek M
Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
[TBL] [Abstract][Full Text] [Related]
3. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
4. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
Chalasani N; Gitlin N
Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
[No Abstract] [Full Text] [Related]
6. Nutrition in the management of hepatic encephalopathy.
Srivastava N; Singh N; Joshi YK
Trop Gastroenterol; 2003; 24(2):59-62. PubMed ID: 14603821
[TBL] [Abstract][Full Text] [Related]
7. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
[TBL] [Abstract][Full Text] [Related]
8. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
Zavaglia C; Brivio M; Losacco E; Onida L
Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
[TBL] [Abstract][Full Text] [Related]
9. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of hepatic encephalopathy with oral branched-chain amino acids: I. Acute hepatic encephalopathy].
Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):116-22. PubMed ID: 3659529
[No Abstract] [Full Text] [Related]
12. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
Kanematsu T; Koyanagi N; Matsumata T; Kitano S; Takenaka K; Sugimachi K
Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
[TBL] [Abstract][Full Text] [Related]
13. Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment.
Bombardieri G; Gigli GL; Bernardi L; Ferri R; Grassi C; Milani A
Hepatogastroenterology; 1985 Feb; 32(1):3-7. PubMed ID: 3921445
[TBL] [Abstract][Full Text] [Related]
14. The role of nutrition in hepatic encephalopathy.
Schulz GJ; Campos AC; Coelho JC
Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):275-80. PubMed ID: 18403924
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
Bauer AG; Wilson JH; Lamberts SW; Blom W
Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
[TBL] [Abstract][Full Text] [Related]
16. [Branched-chain amino acids and their ketoanalogs: therapeutic uses in patients with chronic liver or kidney failure].
Bode JC
Internist (Berl); 1985 Jul; 26(7):388-98. PubMed ID: 3897107
[No Abstract] [Full Text] [Related]
17. [Parenteral and enteral nutritional support for patients with liver cirrhosis].
Masuzawa M; Okuyama T; Kato M
Nihon Rinsho; 1994 Jan; 52(1):203-8. PubMed ID: 8114294
[TBL] [Abstract][Full Text] [Related]
18. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC
Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
[TBL] [Abstract][Full Text] [Related]
19. Role of branched-chain amino acids in liver disease: the evidence for and against.
Khanna S; Gopalan S
Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):297-303. PubMed ID: 17414498
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic significance of branched-chain keto and amino acids].
Schauder P
Internist (Berl); 1984 May; 25(5):313-9. PubMed ID: 6376411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
